Radiotherapy after chemotherapy for metastatic seminoma—a diminishing role
- 31 May 1997
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 33 (6), 829-835
- https://doi.org/10.1016/s0959-8049(97)00033-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Gallium scans in the evaluation of residual masses after chemotherapy for seminoma.Journal of Clinical Oncology, 1995
- Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874British Journal of Cancer, 1995
- Sites of relapse in seminoma treated with single agent carboplatin chemotherapy: Implications for further managementClinical Oncology, 1992
- The activity of single-agent carboplatin in advanced seminomaEuropean Journal of Cancer, 1992
- Alternatives to Radiotherapy in the Management of SeminomaBJU International, 1990
- Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation TherapyRadiotherapy and Oncology, 1989
- Testicular Seminoma: The M. D. Anderson Experience. An Analysis of Pathological and Patient Characteristics, and Treatment RecommendationsJournal of Urology, 1988
- Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8)British Journal of Cancer, 1985
- Seminoma of the testis: Results of treatment and patterns of failure after radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISThe Lancet, 1979